Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 479, doi. 10.1007/s40273-024-01372-0
- By:
- Publication type:
- Article
Works matching IS 11707690 AND DT 2024 AND VI 42 AND IP 5
Results: 9
1
2
Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 583, doi. 10.1007/s40273-024-01360-4
- By:
- Publication type:
- Article
3
Economic Evaluations of Treatments for Duchenne Muscular Dystrophy: The Caregiver QALY Trap.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 475, doi. 10.1007/s40273-024-01367-x
- By:
- Publication type:
- Article
4
Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 569, doi. 10.1007/s40273-024-01358-y
- By:
- Publication type:
- Article
5
Reply to Comment on "A Framework for Fair Pricing of Medicines".
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 607, doi. 10.1007/s40273-024-01369-9
- By:
- Publication type:
- Article
6
Content Comparison of Quality-of-Life Instruments Used in Economic Evaluations of Sleep Disorder Interventions: A Systematic Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 507, doi. 10.1007/s40273-023-01349-5
- By:
- Publication type:
- Article
7
Comment on: A Framework for the Fair Pricing of Medicines.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 605, doi. 10.1007/s40273-024-01368-w
- By:
- Publication type:
- Article
8
Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 487, doi. 10.1007/s40273-024-01363-1
- By:
- Publication type:
- Article
9
Critical Examination of Modeling Approaches Used in Economic Evaluations of First-Line Treatments for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: A Systematic Literature Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 527, doi. 10.1007/s40273-024-01362-2
- By:
- Publication type:
- Article